Bildkälla: Stockfoto

NeoDynamics Q3: No sales but important regulatory milestone - Redeye

Redeye lowers its fair value range for NeoDynamics following the continuous assessment of the company’s financial position and an increased WACC due to a higher risk-free rate. Net sales were, as expected, practically zero in the quarter, but with a US launch during Q1 2023 and commenced production in the EU, we believe next year entails improved growth opportunities.

Redeye lowers its fair value range for NeoDynamics following the continuous assessment of the company’s financial position and an increased WACC due to a higher risk-free rate. Net sales were, as expected, practically zero in the quarter, but with a US launch during Q1 2023 and commenced production in the EU, we believe next year entails improved growth opportunities.
Börsvärldens nyhetsbrev
ANNONSER